Coverage
-
February 15, 2017
A New Jersey federal judge on Wednesday found that Dr. Reddy's Laboratories Inc.'s planned generic version of Helsinn Healthcare SA's anti-nausea drug Aloxi infringes three patents for the drug and rejected Dr. Reddy's contention that two of those patents are invalid.
1 other articles on this case.
View all »